https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Systemic treatment of HER2-positive metastatic breast cancer: a systematic review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20551 Sat 24 Mar 2018 08:02:39 AEDT ]]> A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18630 Mon 20 Jul 2015 16:38:11 AEST ]]> Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19927 Mon 06 Aug 2018 11:18:23 AEST ]]>